Estimating Drug Costs: How do Manufacturer Net Prices Compare with Other Common US Price References? [PDF]
Pharmacoeconomics, 2018 Mattingly TJ +4 more
europepmc +1 more source
Innovative assessment of inpatient and pulmonary drug costs for children with cystic fibrosis. [PDF]
Pediatr Pulmonol, 2016 Levy JF, Rosenberg MA, Farrell PM.
europepmc +1 more source
Brand-name drug costs expected to rise under CETA. [PDF]
CMAJ, 2017 Sibbald B.
europepmc +1 more source
Rising Drug Costs Drives the Growth of Pharmacy Benefit Managers Exclusion Lists: Are Exclusion Decisions Value-Based? [PDF]
Health Serv Res, 2018 Cohen JP +3 more
europepmc +1 more source
A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses. [PDF]
Value Health, 2018 Levy J, Rosenberg M, Vanness D.
europepmc +1 more source
Regulatory Solutions to the Problem of High Generic Drug Costs. [PDF]
Open Forum Infect Dis, 2015 Luo J, Sarpatwari A, Kesselheim AS.
europepmc +1 more source
Prescription Drug Costs Among People With Alzheimer Disease and Related Dementias.
JAMA Netw OpenJang S, McCoy RG, Chen J.
europepmc +1 more source
The impact of dementia on drug costs in older people: results from the SNAC study. [PDF]
BMC Neurol, 2016 Sköldunger A +4 more
europepmc +1 more source
Functional Limitations, Medication Support, and Responses to Drug Costs among Medicare Beneficiaries. [PDF]
PLoS One, 2015 Whaley C, Reed M, Hsu J, Fung V.
europepmc +1 more source
Canada-EU trade agreement expected to increase drug costs. [PDF]
CMAJ, 2013 Eggertson L.
europepmc +1 more source